BMJ  2004;329 (13 November), doi:10.1136/bmj.329.7475.0

Thalassaemia screening in Iran works

A primary care led genetic screening programme for thalassaemia in Iran has proved feasible, acceptable, and effective. Samavat and Modell (p 1134) describe the development of Iran's national programme, which has resulted in a 70% reduction in expected births of affected infants. It provides a model for other countries, including developed countries, seeking to implement comprehensive, equitable, genetic screening programmes for haemoglobin disorders (p 1115).

Credit: ATTA KENARE/AFP/GETTY


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Lessons from thalassaemia screening in Iran
Arnold Christianson, Allison Streetly, and Aamra Darr
BMJ 2004 329: 1115-1117. [Extract] [Full Text] [PDF]

Iranian national thalassaemia screening programme
Ashraf Samavat and Bernadette Modell
BMJ 2004 329: 1134-1137. [Full Text] [PDF]




Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview